1. Home
  2. ANTX vs INGN Comparison

ANTX vs INGN Comparison

Compare ANTX & INGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AN2 Therapeutics Inc.

ANTX

AN2 Therapeutics Inc.

HOLD

Current Price

$4.79

Market Cap

170.6M

Sector

Health Care

ML Signal

HOLD

Logo Inogen Inc

INGN

Inogen Inc

HOLD

Current Price

$6.41

Market Cap

172.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANTX
INGN
Founded
2017
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Specialties
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
170.6M
172.4M
IPO Year
2022
2013

Fundamental Metrics

Financial Performance
Metric
ANTX
INGN
Price
$4.79
$6.41
Analyst Decision
Buy
Strong Buy
Analyst Count
1
4
Target Price
$2.00
$11.25
AVG Volume (30 Days)
209.3K
341.9K
Earning Date
05-13-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
32.56
43.42
EPS
N/A
N/A
Revenue
N/A
$348,668,000.00
Revenue This Year
N/A
$8.03
Revenue Next Year
N/A
$7.76
P/E Ratio
N/A
N/A
Revenue Growth
N/A
3.86
52 Week Low
$1.00
$5.34
52 Week High
$6.91
$9.13

Technical Indicators

Market Signals
Indicator
ANTX
INGN
Relative Strength Index (RSI) 59.60 42.70
Support Level $1.06 $5.97
Resistance Level $5.09 $6.93
Average True Range (ATR) 0.44 0.35
MACD -0.02 -0.08
Stochastic Oscillator 65.64 19.05

Price Performance

Historical Comparison
ANTX
INGN

About ANTX AN2 Therapeutics Inc.

AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.

About INGN Inogen Inc

Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.

Share on Social Networks: